Related Experiment Videos
Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU
The New England Journal of Medicine
|August 26, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2001
Burnout: caring for the caregivers.
The oncologist·2000
Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes.
The New England journal of medicine·2026
Adult Attention Deficit-Hyperactivity Disorder.
The New England journal of medicine·2026
Long-Acting HIV Therapy in African Adults with Adherence Challenges.
The New England journal of medicine·2026
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis.
The New England journal of medicine·2026